Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease: a Non-inferiority Investigation
Conditions
Interventions
BUFY02 eye drops in single-dose containers
TRB02 eye drops in single-dose containers
Locations
5
Austria
Medical University Graz
Graz, Austria
VIROS
Vienna, Austria
CHRU Brest
Brest, France
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
CHU Nice
Nice, France
Start Date
September 25, 2025
Primary Completion Date
March 1, 2027
Completion Date
June 1, 2027
Last Updated
February 5, 2026
NCT07463950
NCT07363824
NCT07396441
NCT05865379
NCT06841471
NCT07453212
Lead Sponsor
TRB Chemedica International SA
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions